The search for a magic bullet to kill only cancer cells has been on for years.
© Getty Images
New candidate cancer drug does damage only in tumours.
A new drug turns lethal only when it reaches cancer cells. In healthy cells it is harmless. Though not yet shown to work in humans, it is a step towards a magic bullet to knock out tumour cells selectively, with minimal side effects.
The drug works in mice implanted with human tumours, say chemists Lutz Tietze and colleagues at the University of Gottingen in Germany. Before being treated with the drug, the mice are given an enzyme to activate it that sticks only to the human tumour cells, ignoring healthy mouse cells. So the drug is safe until the enzyme activates it in the tumour. Then it destroys the cancerous cells1.
Most existing chemotherapy is toxic to normal cells as well as cancerous ones. This causes severe side effects, such as a depressed immune system. Cancer researchers long for a magic bullet: a drug that works only where it is needed.
The warhead of the Gottingen antitumour molecule is a ring of three carbon atoms. This ring is highly strained and apt to burst open. Open, it is a reactive molecule that wreaks havoc among the nucleic acid molecules essential for normal cell function. The chemists copied this trick from a highly toxic antibiotic produced by a fungus.
So that their molecular bomb does not detonate everywhere in the body, the team have made a ’prodrug’. This is like the natural antibiotic but without the strained ring and with a sugar safety-catch. Once the sugar is clipped off, the molecule rearranges itself into a three-atom ring, and proceeds to do its toxic business.
Tietze’s team uses an enzyme to cut away the sugar safety-catch. An antibody on the enzyme acts as a tumour-specific hook. Such antibodies linked to toxic or radioactive molecules have long been explored for making magic-bullet drugs; none has yet found clinical use.
The advantage of this enzyme-activated approach, originally developed in the 1980s, is that the drug isn’t even activated until it reaches the target site. The selectivity of the damage still depends on antibody’s ability to hook onto the right cells, and on the absence of other enzymes in the body that also activate the prodrug.
Whether the idea will work cleanly enough in humans remains to be seen.
PHILIP BALL | © Nature News Service
How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine
Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
22.01.2018 | Power and Electrical Engineering
22.01.2018 | Power and Electrical Engineering
22.01.2018 | Agricultural and Forestry Science